… The legal initiatives, including Paediatric Drug Regulation in the EU, and effective research
tools, including population pharmacokinetics, are two important stimulants to boost further …

… a population pharmacokinetic model for lidocaine for the treatment of neonatal seizures
that … therapy, which was able to describe both preterm and term neonates with a PNA of 0–10 …

… and bioavailability of caffeine in extremely premature infants undergoing extubation has …
develop a population pharmacokinetic model for caffeine in extremely low birth weight infants. A …

… develop and validate a population pharmacokinetic model for R… 24-hour intervals to preterm
newborn infants aged from <6 hours … The aim of the present pharmacokinetic analysis was to …

… The population PK parameter estimate for elimination half-life in the present study … premature
neonates, with inverse proportionality to PNA (2, 4, 8). In our cohort of premature neonates, …

… piperacillin/tazobactam population PK model generated in our study provided a rational
basis for the development of preliminary dosing guidelines to neonates and infants less than 2 …

… use in neonates by overcoming … population pharmacokinetics of azlocillin in neonates
using real-world data, to make subsequent dose recommendations and to test these in neonates …

… This article summarises the published population PK studies of antibiotics used in neonates.
Our literature search was based on the results of a recent point prevalence study where 12 …

… The pharmacokinetics (PK) of amoxicillin in asphyxiated newborns undergoing moderate
hypothermia were quantified using prospective data (N = 125). The population PK was …

… to determine population pharmacokinetic parameters of vancomycin in neonatal patients …
-clavulanic acid and spironolactone on the pharmacokinetics of vancomycin in this cohort of …